Business Description
Semnur Pharmaceuticals Inc
NAICS : 541714
SIC : 2834
ISIN : US81686G1058
Total Employee Number:
10Description
Semnur Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its main product candidate, SP-102 (10 mg, dexamethasone sodium phosphate viscous gel), is being developed as a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe LRP (also known as sciatica), containing no preservatives, surfactants, solvents, or particulates.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -12.86 | |||||
Debt-to-Equity | -0.78 | |||||
Debt-to-EBITDA | -0.12 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -265.8 | |||||
3-Year EPS without NRI Growth Rate | -265.3 | |||||
3-Year FCF Growth Rate | -19.5 | |||||
3-Year Book Growth Rate | 14.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.09 | |||||
9-Day RSI | 36.54 | |||||
14-Day RSI | 35.4 | |||||
3-1 Month Momentum % | -37.5 | |||||
6-1 Month Momentum % | -41.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.12 | |||||
Quick Ratio | 0.12 | |||||
Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.4 | |||||
Shareholder Yield % | 13.26 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -3972.9 | |||||
ROIC % | -2801.92 | |||||
3-Year ROIIC % | -3870.79 | |||||
ROC (Joel Greenblatt) % | -4788.92 | |||||
Moat Score | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -1.03 | |||||
EV-to-EBITDA | -1.03 | |||||
EV-to-FCF | -20.79 | |||||
Earnings Yield (Greenblatt) % | -97.09 | |||||
FCF Yield % | -5.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SMNR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Semnur Pharmaceuticals Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.794 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 35.4 | ||
| 14-Day ATR ($) | 0.541059 | ||
| 20-Day SMA ($) | 1.44671 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.25 - 23 | ||
| Shares Outstanding (Mil) | 230.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Semnur Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Semnur Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Semnur Pharmaceuticals Inc Frequently Asked Questions
What is Semnur Pharmaceuticals Inc(SMNR)'s stock price today?
The current price of SMNR is $0.65. The 52 week high of SMNR is $23.00 and 52 week low is $0.25.
When is next earnings date of Semnur Pharmaceuticals Inc(SMNR)?
The next earnings date of Semnur Pharmaceuticals Inc(SMNR) is .
Does Semnur Pharmaceuticals Inc(SMNR) pay dividends? If so, how much?
Semnur Pharmaceuticals Inc(SMNR) does not pay dividend.
Guru Commentaries on OTCPK:SMNR
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Semnur Pharmaceuticals Inc
Headlines
See More- 1
Jul 07, 2026
Semnur Pharmaceuticals signs binding term sheet for $100M equity investment from iHolding Group
Seeking Alpha • 5:36am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers